CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Shinpoong Pharmaceutical Co Ltd (Parent) is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Shinpoong Pharmaceutical Co Ltd (Parent)
7, Wonsi-ro, Danwon-gu
Phone: +82 314916191p:+82 314916191 ANSAN, 15610  South Korea Fax: +82 221893439f:+82 221893439

Business Summary
Shin Pooong Pharm., Co. Ltd is a Korea-based company mainly engaged in the manufacture of pharmaceuticals. The Company's product portfolio consists of antibiotics, cardiovascular drugs, anti-cancer drugs, psychoneurotic drugs, antirheumatic drugs, antidiabetics, antifungal agents, antihistamines, antiviral agents, benign prostatic hyperplasia (BPH) drugs and trichogens. The Company also provides active pharmaceutical ingredients (APIs) synthesized by the Company, including non-steroidal anti-inflammatory drugs (NSAIDs), cardiovascular drugs, anti-ulcer drugs, respiratory drugs, antispasmodics drugs and others. The Company distributes its products within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/202112/31/2021Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Je ManYoo 66 3/21/2014 3/21/2014
Managing Director CheongJoo 49 1/1/2016 1/1/2016
Managing Director Chun SikNoh 70 1/1/2018
11 additional Officers and Directors records available in full report.

General Information
Number of Employees: 835 (As of 12/31/2013)
Outstanding Shares: 49,271,029 (As of 9/30/2022)
Shareholders: 2,398
Fax Number: +82 221893439


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, September 27, 2023